Cost considerations surrounding current and future anticoagulant therapies

Margaret C. Fang, MD, MPH
Department of Medicine Hospitalist Group, University of California, San Francisco

Tracy Minichiello, MD
Department of Medicine Hospitalist Group, University of California, San Francisco

Andrew D. Auerbach, MD, MPH
Department of Medicine Hospitalist Group, University of California, San Francisco

Correspondence: Andrew D. Auerbach, MD, MPH, UCSF Box 0131, 505 Parnassus Avenue, University of California, San Francisco, San Francisco, CA 94143–0131; ada@medicine.ucsf.edu

Drs. Fang and Auerbach have indicated that they have nothing to disclose.

Dr. Minichiello has received an unrestricted educational grant from AstraZeneca and was a one-time consultant for GlaxoSmithKline.

Margaret C. Fang, MD, MPH
Department of Medicine Hospitalist Group, University of California, San Francisco

Tracy Minichiello, MD
Department of Medicine Hospitalist Group, University of California, San Francisco

Andrew D. Auerbach, MD, MPH
Department of Medicine Hospitalist Group, University of California, San Francisco

Correspondence: Andrew D. Auerbach, MD, MPH, UCSF Box 0131, 505 Parnassus Avenue, University of California, San Francisco, San Francisco, CA 94143–0131; ada@medicine.ucsf.edu

Drs. Fang and Auerbach have indicated that they have nothing to disclose.

Dr. Minichiello has received an unrestricted educational grant from AstraZeneca and was a one-time consultant for GlaxoSmithKline.

Margaret C. Fang, MD, MPH
Department of Medicine Hospitalist Group, University of California, San Francisco

Tracy Minichiello, MD
Department of Medicine Hospitalist Group, University of California, San Francisco

Andrew D. Auerbach, MD, MPH
Department of Medicine Hospitalist Group, University of California, San Francisco

Correspondence: Andrew D. Auerbach, MD, MPH, UCSF Box 0131, 505 Parnassus Avenue, University of California, San Francisco, San Francisco, CA 94143–0131; ada@medicine.ucsf.edu

Drs. Fang and Auerbach have indicated that they have nothing to disclose.

Dr. Minichiello has received an unrestricted educational grant from AstraZeneca and was a one-time consultant for GlaxoSmithKline.